PMV Pharmaceuticals, Inc. (PMVP) Tops Q2 EPS by 33c

PMV Pharmaceuticals, Inc. (NASDAQ: PMVP) reported Q2 EPS of ($0.02), $0.33 better than the analyst estimate of ($0.35).

For earnings history and earnings-related data on PMV Pharmaceuticals, Inc. (PMVP) click here.

You May Also Be Interested In

• Piper Sandler sees Google TPU sales hitting $104BN by 2028
• Increasing unusual call option volume: KOD AMTX VET ITB MDB SOLZ ALGM DC PACS CM PLNT DASH AMPX
• MongoDB (MDB) call put ratio 1.3 calls to 1 put after CEO departure, share price down 19%